chartexchange

Sellas Life Sciences Stock Triples After Cancer Vaccine Data

Bloomberg | Nov 17, 2026 11:52 AM EST

Sellas Life Sciences Group Inc. surged after the drug developer reported positive late-stage trial results for an experimental cancer vaccine to treat an aggressive form of blood cancer.

Read original article